CompletedNot applicableNCT00290641
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Claudio G. Brunstein, MD, PhD, FNP-BCMasonic Cancer Center, University of Minnesota
- Intervention
- filgrastim(biological)
- Enrollment
- 68 enrolled
- Eligibility
- 45 years · All sexes
- Timeline
- 2001 – 2006
Study locations (1)
- University of Minnesota Cancer Center, Minneapolis, Minnesota, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00290641 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.